Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03543865 · ClinicalTrials.gov registry record · NA
Southwest Hub for American Indian Youth Suicide Prevention Research
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
NCT03543865 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 304 participants.
The verdict
NCT03543865, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
Study Summary
1. To use a SMART design to evaluate which of four sequences of New Hope (NH), Elders Resilience (ER) and Case Management (CM) have the greater effects on immediate and longer-term suicidal ideation (primary outcome) and resilience (secondary outcome) among American Indian (AI) adolescents ages 10-29 identified at risk for suicide. Hypotheses: i. New Hope vs. CM alone will significantly reduce participant suicidal ideation. ii. Elders Resilience vs. CM alone will significantly improve participant resilience. iii. New Hope followed by Elders Resilience will have the strongest effects on suicidal ideation and resilience. iv. CM alone will have the weakest effects of all combinations. Secondary Aims: 2. To examine mediators and moderators of treatment effectiveness and sequencing in order to determine which types and sequence of interventions is best suited for which youth. 3. To assess the acceptability, feasibility and capacity for sustainability of the Hub's key intervention components (Surveillance/Case Management, New Hope and Elders' Resilience) from the perspective of multiple stakeholders as they are implemented across different tribes.
Interventions
- BEHAVIORAL New Hope (NH)
- BEHAVIORAL Elders Resilience (ER)
- OTHER Case Management (CM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03543865
The ClinicalTrials.gov registry entry for NCT03543865 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which New Hope (NH) is the first listed.
NCT03543865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03543865 about?
NCT03543865 is a clinical study titled "Southwest Hub for American Indian Youth Suicide Prevention Research". 1. To use a SMART design to evaluate which of four sequences of New Hope (NH), Elders Resilience (ER) and Case Management (CM) have the greater effects on immediate and longer-term suicidal ideation (primary outcome) and resilience (secondary outcome) among American Indian (AI) adolescents ages 10-2...
What is the current status of trial NCT03543865?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2019-03-25. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT03543865?
The interventions under investigation include: New Hope (NH) (BEHAVIORAL), Elders Resilience (ER) (BEHAVIORAL), Case Management (CM) (OTHER).
Who is sponsoring clinical trial NCT03543865?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.